USANA Health Sciences, Inc.
USNA
$14.96
$0.533.67%
NYSE
| 07/04/2026 | 04/04/2026 | 01/03/2026 | 09/27/2025 | 06/28/2025 | |
|---|---|---|---|---|---|
| Revenue | 223.27M | 250.22M | 226.20M | 213.67M | 235.85M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 223.27M | 250.22M | 226.20M | 213.67M | 235.85M |
| Cost of Revenue | 48.34M | 59.44M | 49.41M | 48.82M | 50.18M |
| Gross Profit | 174.93M | 190.78M | 176.79M | 164.86M | 185.66M |
| SG&A Expenses | 165.79M | 176.91M | 159.54M | 163.63M | 168.95M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 214.13M | 236.34M | 208.95M | 212.45M | 219.13M |
| Operating Income | 9.14M | 13.87M | 17.25M | 1.22M | 16.72M |
| Income Before Tax | -18.90M | 15.47M | 4.18M | 1.79M | 18.82M |
| Income Tax Expenses | 9.05M | 8.51M | 5.77M | 8.46M | 8.37M |
| Earnings from Continuing Operations | -27.95M | 6.96M | -1.60M | -6.66M | 10.44M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 6.57M | 556.00K | -180.00K | 140.00K | -789.00K |
| Net Income | -21.38M | 7.52M | -1.78M | -6.52M | 9.66M |
| EBIT | 9.14M | 13.87M | 17.25M | 1.22M | 16.72M |
| EBITDA | 16.82M | 22.15M | 25.81M | 9.14M | 24.46M |
| EPS Basic | -1.16 | 0.41 | -0.10 | -0.36 | 0.52 |
| Normalized Basic EPS | 0.70 | 0.56 | 0.59 | 0.07 | 0.59 |
| EPS Diluted | -1.16 | 0.41 | -0.10 | -0.36 | 0.52 |
| Normalized Diluted EPS | 0.70 | 0.56 | 0.59 | 0.07 | 0.59 |
| Average Basic Shares Outstanding | 18.49M | 18.40M | 18.30M | 18.29M | 18.51M |
| Average Diluted Shares Outstanding | 18.49M | 18.41M | 18.30M | 18.29M | 18.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |